---
pmid: '28525742'
title: Ubiquitin Modification by the E3 Ligase/ADP-Ribosyltransferase Dtx3L/Parp9.
authors:
- Yang CS
- Jividen K
- Spencer A
- Dworak N
- Ni L
- Oostdyk LT
- Chatterjee M
- Kuśmider B
- Reon B
- Parlak M
- Gorbunova V
- Abbas T
- Jeffery E
- Sherman NE
- Paschal BM
journal: Mol Cell
year: '2017'
full_text_available: false
pmcid: PMC5556935
doi: 10.1016/j.molcel.2017.04.028
---

# Ubiquitin Modification by the E3 Ligase/ADP-Ribosyltransferase Dtx3L/Parp9.
**Authors:** Yang CS, Jividen K, Spencer A, Dworak N, Ni L, Oostdyk LT, Chatterjee M, Kuśmider B, Reon B, Parlak M, Gorbunova V, Abbas T, Jeffery E, Sherman NE, Paschal BM
**Journal:** Mol Cell (2017)
**DOI:** [10.1016/j.molcel.2017.04.028](https://doi.org/10.1016/j.molcel.2017.04.028)
**PMC:** [PMC5556935](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5556935/)

## Abstract

1. Mol Cell. 2017 May 18;66(4):503-516.e5. doi: 10.1016/j.molcel.2017.04.028.

Ubiquitin Modification by the E3 Ligase/ADP-Ribosyltransferase Dtx3L/Parp9.

Yang CS(1), Jividen K(1), Spencer A(1), Dworak N(1), Ni L(1), Oostdyk LT(2), 
Chatterjee M(1), Kuśmider B(1), Reon B(3), Parlak M(4), Gorbunova V(5), Abbas 
T(6), Jeffery E(7), Sherman NE(7), Paschal BM(8).

Author information:
(1)Center for Cell Signaling, University of Virginia, West Complex, 1335 Lee 
Street, Charlottesville, VA 22908, USA.
(2)Center for Cell Signaling, University of Virginia, West Complex, 1335 Lee 
Street, Charlottesville, VA 22908, USA; Department of Biochemistry and Molecular 
Genetics, University of Virginia, PO Box 800733, Charlottesville, VA 22908, USA.
(3)Department of Biochemistry and Molecular Genetics, University of Virginia, PO 
Box 800733, Charlottesville, VA 22908, USA.
(4)Department of Radiation Oncology, University of Virginia, PO Box 800383, 
Charlottesville, VA 22908, USA.
(5)Department of Biology, University of Rochester, 434 Hutchison Hall, 
Rochester, NY 14627, USA.
(6)Center for Cell Signaling, University of Virginia, West Complex, 1335 Lee 
Street, Charlottesville, VA 22908, USA; Department of Biochemistry and Molecular 
Genetics, University of Virginia, PO Box 800733, Charlottesville, VA 22908, USA; 
Department of Radiation Oncology, University of Virginia, PO Box 800383, 
Charlottesville, VA 22908, USA.
(7)W. M. Keck Biomedical Mass Spectrometry Laboratory, University of Virginia, 
Pinn Hall, Room 1034, Charlottesville, VA 22908, USA.
(8)Center for Cell Signaling, University of Virginia, West Complex, 1335 Lee 
Street, Charlottesville, VA 22908, USA; Department of Biochemistry and Molecular 
Genetics, University of Virginia, PO Box 800733, Charlottesville, VA 22908, USA. 
Electronic address: paschal@virginia.edu.

ADP-ribosylation of proteins is emerging as an important regulatory mechanism. 
Depending on the family member, ADP-ribosyltransferases either conjugate a 
single ADP-ribose to a target or generate ADP-ribose chains. Here we 
characterize Parp9, a mono-ADP-ribosyltransferase reported to be enzymatically 
inactive. Parp9 undergoes heterodimerization with Dtx3L, a histone E3 ligase 
involved in DNA damage repair. We show that the Dtx3L/Parp9 heterodimer mediates 
NAD+-dependent mono-ADP-ribosylation of ubiquitin, exclusively in the context of 
ubiquitin processing by E1 and E2 enzymes. Dtx3L/Parp9 ADP-ribosylates the 
carboxyl group of Ub Gly76. Because Gly76 is normally used for Ub conjugation to 
substrates, ADP-ribosylation of the Ub carboxyl terminus precludes 
ubiquitylation. Parp9 ADP-ribosylation activity therefore restrains the E3 
function of Dtx3L. Mutation of the NAD+ binding site in Parp9 increases the DNA 
repair activity of the heterodimer. Moreover, poly(ADP-ribose) binding to the 
Parp9 macrodomains increases E3 activity. Dtx3L heterodimerization with Parp9 
enables NAD+ and poly(ADP-ribose) regulation of E3 activity.

Copyright © 2017 Elsevier Inc. All rights reserved.

DOI: 10.1016/j.molcel.2017.04.028
PMCID: PMC5556935
PMID: 28525742 [Indexed for MEDLINE]
